Recorded Events

Post-IAS Webinar with Discussion of Application to Clinical Practice

Watch on demand our discussion on ViiV-sponsored data presented at the 2023 IAS Conference with a panel discussion.

Women’s PrEP Disparity Webinar with Expert Panel Discussion

Kimberly Smith, MD, MPH
SVP and Head, Research & Development
ViiV Healthcare

Toyin Nwafor, MD
Sr. Medical Director, HIV Prevention
ViiV Healthcare

Heidi Swygard. MD, MPH
Regional Medical Lead, PrEP
ViiV Healthcare

POST CROI 2023 Webinar

Expert Panel Discussion of 2023 CROI ViiV-Sponsored Data

POST AIDS 2022 Webinar

Expert Panel Discussion of 2022 AIDS ViiV-Sponsored Data

Utilizing and Applying Findings from Observational Studies in AIDS Research

Shelly Dhir, PharmD Sr. Director, Portfolio Medical Lead
Dr. Rick Elion, MD Director of Clinical Research, Washington Health Institute and Clinical Professor of Medicine George Washington University School of Medicine

Using Fewer HIV Treatments When Treating HIV Long Term

Andrew Zolopa, MD VP, Head, North American Medical Affairs ViiV Healthcare
Dr. Babafemi Taiwo, MD, MBBS Gene Stollerman Professor of Medicine and Chief of the Division of Infectious Diseases Northwestern University

Discussing CABENUVA Data at AIDS 2022

Bruce Gilliam, MD, FACP Sr. Medical Director, North American Medical Affairs
Dr. Moti Ramgopal, MD, FIDSA, FACP Associate Professor of Medicine Medical Director Midway Research Center and Found of Midway Specialty Care Centers

Discussing the BRIGHTE Study at AIDS 2022

Bruce Gilliam, MD, FACP Sr. Medical Director, North American Medical Affairs
Dr. Moti Ramgopal, MD, FIDSA, FACP Associate Professor of Medicine Medical Director Midway Research Center and Found of Midway Specialty Care Centers

Caring for Patients with Multidrug Resistant (MDR) HIV - A Focus on Patient Identification and ARV Management with Q&A

Alftan Dyson, PharmD | Bruce Gilliam, MD | Elizabeth Race, MD, MPH| Moti Ramgopal, MD, FACP, FIDSA

Post Fall Conference 2021 Webinar

Dr. Andrew Zolopa, ViiV Medical Experts

Post-IAS 2021 Webinar

Dr. Andrew Zolopa, ViiV Medical Experts

The ABCs of CAB: Incorporating Long-Acting Cabenuva into Clinical Practice

Paula Teichner, PharmD, AAHIVP, Regional Medical Lead

Post-CROI 2021 Webinar

Andrew Zolopa, MD, VP, Head, North America Medical Affairs

STAT 24 Week: Feasibility, Efficacy and Safety

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

TANGO 96 Week: Efficacy and Safety

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

GEMINI 144 Week: Efficacy and Safety

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

GEMINI 48 Week: Adherence Analysis

Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir